KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Thermo Fisher Scientific (TMO) EBT Margin (2016 - 2025)

Historic EBT Margin for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to 16.42%.

  • Thermo Fisher Scientific's EBT Margin fell 200.0% to 16.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 16.22%, marking a year-over-year increase of 900.0%. This contributed to the annual value of 16.41% for FY2024, which is 17200.0% up from last year.
  • As of Q3 2025, Thermo Fisher Scientific's EBT Margin stood at 16.42%, which was down 200.0% from 15.74% recorded in Q2 2025.
  • Thermo Fisher Scientific's 5-year EBT Margin high stood at 27.79% for Q2 2021, and its period low was 12.73% during Q2 2023.
  • In the last 5 years, Thermo Fisher Scientific's EBT Margin had a median value of 16.44% in 2024 and averaged 17.49%.
  • Data for Thermo Fisher Scientific's EBT Margin shows a peak YoY increase of 145000bps (in 2021) and a maximum YoY decrease of -100600bps (in 2021) over the last 5 years.
  • Over the past 5 years, Thermo Fisher Scientific's EBT Margin (Quarter) stood at 17.4% in 2021, then decreased by -11bps to 15.52% in 2022, then increased by 3bps to 15.98% in 2023, then increased by 7bps to 17.03% in 2024, then dropped by -4bps to 16.42% in 2025.
  • Its last three reported values are 16.42% in Q3 2025, 15.74% for Q2 2025, and 15.63% during Q1 2025.